JMP Securities Maintains Market Outperform on Neuronetics, Lowers Price Target to $3
JMP Securities Maintains Market Outperform on Neuronetics, Lowers Price Target to $3
JMP證券分析師David Turkaly維持對neuronetics的市場表現並將目標價格下調至$3。
JMP Securities analyst David Turkaly maintains Neuronetics (NASDAQ:STIM) with a Market Outperform and lowers the price target from $7 to $3.
JMP證券分析師David Turkaly維持對neuronetics的市場表現,並將目標價格從$7下調至$3。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。